摘要
尾加压素Ⅱ(UⅡ)是迄今发现最强的缩血管活性肽,对心血管系统具有复杂的调节作用。研究表明,UⅡ可能在血管和心肌重塑性疾病发生、发展过程中发挥重要作用。本文就UⅡ在血管功能调节及血管重塑中的作用及其机制作一综述。
出处
《汕头大学医学院学报》
2010年第3期184-187,共4页
Journal of Shantou University Medical College
参考文献19
-
1ISHIHATA A,SAKAI M,KATANO Y.Vascular contractile effect of urotensin Ⅱ in young and aged rats:influence of a-ging and contribution ofendothelial nitric oxide[J].Peptides,2006,27:80-86.
-
2STIRRAT A,GALLAGHER M,DOUGLAS S A.Potent vasodilator responses to human urotensin-Ⅱ in human pulmonary and abdominal resistance arteries[J].Am J Physiol Heart Circ Physiol,2001,280:H925-928.
-
3LACZA Z,BUSIJA D W.Urotensin-Ⅱ is a nitric oxide-dependent vasodilator in the pial arteries of the newborn pig[J].Life Sci,2006,78:2763-2766.
-
4TSAI C S,LOH S H,LIU J C.Urotensin Ⅱ-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells[J].Atherosclerosis,2009,206(1):86-94.
-
5WATANABE T,TAKAHASHI K,KANOME T.Human urotensin-Ⅱ potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells:comparison with other vasoactive agents and hydrogen peroxide[J].Hypertens Res,2006,29(10):821-831.
-
6戴红艳,葛志明,李永红.尾加压素Ⅱ对自发性高血压大鼠血管外膜成纤维细胞增殖活性及细胞外信号调节激酶1/2磷酸化的影响[J].中国医学科学院学报,2006,28(6):776-780. 被引量:2
-
7ZHANG Y G,LI Y G,WEI R H.Urotensin Ⅱ is an autocrine/paracrine growth factor for aortic adventitia of rat[J].Regul Pept,2008,151(1-3):88-94.
-
8MATSUSAKA S,WWKABAYASHI I.Enhancement of vascular smooth muscle cell migration by urotensin Ⅱ[J].Naunyn Schmiedebergs Arch Pharmacol,2006,3735:381-386.
-
9ZHANG Y G,LI J,LI Y G.Urotensin Ⅱ induces phenotypic differentiation,migration,and collagen synthesis of adventitial fibroblasts from rat aorta[J].J Hypertens,2008,26(6):1119-1126.
-
10WATANABE T,SUGURO T,KANOME T.Human urotensin Ⅱ accelerates foam cell formation in human monocyte-derived macrophages[J].Hypertension,2005,46(4):738-744.
二级参考文献10
-
1Ames RS,Sarau HM,Chambers JK,et al.Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14.Nature,1999,401(16):282-286.
-
2Watanabe T,Pakala R,Katagiri T,et al.Synergistic effect of urotensin Ⅱ with serotonin on vascular smooth muscle cell proliferation.J Hypertens,2001,19(12):2191-2196.
-
3Cheung BM,Leung R,Man YB,et al.Plasma concentration of urotensin Ⅱ is raised in hypertension.J Hypertens,2004,22(7):1341-1344.
-
4Matsushita M,Shichiri M,Imai T,et al.Co-expression of urotensin Ⅱ and its recepror(GPR14) in human cardiovascular and renal tissues.J Hypertens,2001,19(12):2185-2190.
-
5Bradford MM.A rapid and sensitive method for the quantitation of microgram of protein utilizing the principle of protein dye binding.Anal Biochem,1976,72:248-254.
-
6Arribas SM,Hillier C,Gonzalez C,et al.Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy.Hypertension,1997,30(6):1455-1464.
-
7Zhu DL,Herembert T,Marche P.Increased proliferation of adventitial fibroblasts from spontaneously hypertensive rat aorta.J Hypertens,1991,9(12):1161-1168.
-
8Coulouarn Y,Lihrmann I,Jegou S,et al.Cloning of the cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord.Proc Natl Acad Sci,1998,95(26):15803-15808.
-
9Hecquet C,Lefevre G,Valtink M,et al.Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells:ERK and RPE cell proliferation.Invest Ophthalmol Vis Sci,2002,43(9):3091-3098.
-
10杨竞霄,赵连友,郑强荪,尚福军,于心亚,李爱国.尾加压素Ⅱ对乳鼠心肌成纤维细胞增殖的影响及细胞内信号转导机制[J].第四军医大学学报,2004,25(6):519-522. 被引量:6
同被引文献24
-
1刘新林,李玉明.缓激肽β受体与高血压研究进展[J].武警医学,2006,17(3):219-221. 被引量:3
-
2曹永孝,李洁,刘浩,罗国刚.高血压大鼠和高血压患者血管平滑肌α肾上腺素受体的反应性增强作用[J].药学学报,2006,41(10):973-977. 被引量:8
-
3郭学青,张梦翔,高飞,高云颂,李春英.原发性高血压与内皮素升高关系的研究[J].华北国防医药,2007,19(4):9-10. 被引量:4
-
4Ames R S,Sarau H M, Chambers J K, et al. Humanurotensin-II is a potent vasoconstrictor and agonist for theorphan receptor GPR14 [ J]. Nature,1999,401 (6750):282-286.
-
5Liu Q,Pong S S,Zeng Z, et al. Identification of uroten-sin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14[ J]. Biochem Biophys Res Com-mun, 1999,266(1) :174-178.
-
6Simpson C M, Smolich J J, Shekerdemian L S,et al.Urotensin-II contributes to pulmonary vasoconstriction in aperinatal model of persistent pulmonary hypertension ofthe newborn secondary to meconium aspiration syndrome[J]. Pediatr Res, 2010,67(2):150-157.
-
7Maguire J J,Kuc R E, Kleinz M J, et al. Immunocyto-chemical localization of the urotensin-II receptor, UT, torat and human tissues: relevance to function [ J]. Pep-tides, 2008, 29(5) :735-742.
-
8Watanabe T, Arita S,Shiraishi Y,et al. Human uroten-sin II promotes hypertension and atherosclerotic cardiovas-cular diseases[ J]. Curr Med Chem, 2009,16(5) : 550-563.
-
9Song N, Ding W, Chu S, et al. Urotensin II stimulatesvascular endothelial growth factor secretion from adventi-tial fibroblasts in synergy with angiotensin II[ J]. Circ J,2012,76(5) :1267-1273.
-
10Nitescu N, Grimberg E, Guron G. Urotensin-II receptorantagonism does not improve renal haemodynamics orfunction in rats with endotoxin-induced acute kidney injury[J]. Clin Exp Pharmacol Physiol, 2010,37(12) : 1170-1175.
引证文献2
-
1孟庆红,赵翠芬,孔清玉,李福海,李栋,夏伟.尾加压素Ⅱ对大鼠肺动脉平滑肌细胞胶原合成的影响[J].山东大学学报(医学版),2013,51(5):15-19. 被引量:4
-
2姜林峰,莫汉明,张正龙,杨力兵,颜腾亚,汪晨净.几种血管活性物质在高血压中的作用[J].甘肃医药,2016,35(10):748-750. 被引量:5
二级引证文献9
-
1毛玉娟,何亚丽,江华,谢青,王莉,杨锐,申进增,伊琳.当归挥发油对自发性高血压大鼠NO、vWF、EMPs表达水平影响[J].世界科学技术-中医药现代化,2020,22(4):1153-1158. 被引量:7
-
2孙会珍,霍博雅,聂艳辉.二黄汤对哮喘大鼠肺功能及血清和BALF中U-Ⅱ水平的影响[J].中药材,2014,37(9):1651-1653. 被引量:2
-
3苏宪灵,解立新.血浆尾加压素Ⅱ在慢性阻塞性肺疾病的表达及其意义[J].武警医学,2015,26(5):444-445. 被引量:1
-
4韩旭惠,王昌明.肺动脉平滑肌细胞合成和分泌功能及相关调控机制[J].国际呼吸杂志,2016,36(2):157-160.
-
5金禹彤,吴凌韬,陈姗,宣丽华.穴位贴敷对过敏性哮喘大鼠血清转化生长因子β1和尾加压素Ⅱ的影响[J].中医杂志,2017,58(22):1957-1960. 被引量:6
-
6董蓉蓉,李敏,荆鲁.镇肝熄风汤治疗原发性高血压的临床及机制研究进展[J].中国实验方剂学杂志,2018,24(14):222-228. 被引量:25
-
7范翠红,张仪美,贾红玲.针刺降压作用机制研究进展[J].辽宁中医药大学学报,2020,22(12):172-176. 被引量:3
-
8张欣,贾敏,秦巧红,张寒,侯颖,苏兴利,陈玉龙.二苯乙烯苷对血管活性物质引起的体外血管收缩作用的影响[J].中药新药与临床药理,2021,32(8):1114-1119. 被引量:3
-
9刘瑞民,王海慧,施维,徐霁雪,徐丽诗,于扬,徐成.蟾蜍皮肤提取物QUB2419的降压作用及机制初探[J].中国新药杂志,2019,0(3):341-345.
-
1赵建萍.慢性心衰患者的临床护理体会[J].中国中医药现代远程教育,2010,8(23):131-131. 被引量:3
-
2高新明,拜君芳.高血压左室肥厚与左室舒张功能减低的关系[J].中国社区医师(医学专业),2009,11(1):15-15.
-
3富路,戴颖楠,朱立群,万晓京,曹君娴,韩颖,谢荣盛.慢性心功能衰竭患者血浆尾加压素Ⅱ、内皮素和肾上腺髓质素的变化[J].中国动脉硬化杂志,2007,15(3):201-204. 被引量:9
-
4汤正好,臧国庆.内皮素与肝病研究进展[J].国外医学(流行病学.传染病学分册),2005,32(5):296-298. 被引量:1
-
5李军,张勇刚,李玉光.尾加压素II与血管重构(英文)[J].心脏杂志,2007,19(5):606-610.
-
6韩秋,刘彦丽,荣俊芳.高血压左室壁肥厚与左室舒张功能减低的分析[J].中国伤残医学,2011,19(4):39-40.
-
7周华仕,张幸,洪长福.内皮素在肺纤维化发病机制中的作用[J].中华劳动卫生职业病杂志,2004,22(5):379-382. 被引量:3
-
8陈安忠,程莉,欧作英,叶友联.老年男性高血压患者血浆ADM和ET-1含量变化的意义[J].放射免疫学杂志,2007,20(3):216-218. 被引量:3
-
9陈新胜,张勇刚.尾加压素Ⅱ与动脉粥样硬化[J].医学综述,2008,14(6):824-826.